{
    "nct_id": "NCT00814346",
    "title": "Effect of Oral EGb761\u00ae on Brain Glucose Metabolism in Three Groups of Elderly With Memory Complaint, Mild Alzheimer's Disease, and Cognitively Normal Elderly. Phase II, Randomised, Double-blind, Parallel Groups, Placebo-controlled Study",
    "status": "COMPLETED",
    "last_update_time": "2019-01-24",
    "description_brief": "The aim of the study is to evaluate the effect of EGb761\u00ae, in comparison to placebo, on cerebral glucose metabolism, in three groups of elderly patients: newly diagnosed mild Alzheimer's disease (AD), memory complaint patients with cognitive impairment (MC) and memory complaint patients cognitively normal (CNE). The first phase includes four weeks treatment with EGb761\u00ae for all groups, with change in brain glucose metabolism at month 1 using 18 FDG-PET, as primary endpoint which will be followed by an open 17 months follow-up (FU) period with EGb761\u00ae treatment in MC and CNE patients.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "preAssignmentDetails": "A total of 63 participants were screened of which 49 subjects were randomised to either EGb761 and Placebo treatment groups (double-blind period).\n\nThe 49 randomised subjects consisted of three groups of elderly subjects: Cognitively normal elderly (CNE), Memory Complaint (MC) and Alzheimer's Disease (AD).",
            "groups": [
                {
                    "id": "FG000",
                    "title": "EGb761 120 mg",
                    "description": "EGb761 120 mg tablet twice a day for 4 weeks (Double-blind phase) for CNE, MC, and AD patients and 17 months (Open phase) for CNE and MC patients"
                },
                {
                    "id": "FG001",
                    "title": "Placebo",
                    "description": "Placebo 1 tablet twice a day for 4 weeks CNE, MC, and AD patients"
                }
            ],
            "periods": [
                {
                    "title": "Double-blind Phase (4 Weeks)",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "23"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "26"
                                }
                            ]
                        },
                        {
                            "type": "CNE",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "10"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "13"
                                }
                            ]
                        },
                        {
                            "type": "MC",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "10"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "11"
                                }
                            ]
                        },
                        {
                            "type": "AD",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "3"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "23"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "23"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "3"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Not otherwise specified",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Open Phase (17 Months)",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "comment": "Open period was treated with EGB761\u00ae. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)",
                                    "numSubjects": "41"
                                },
                                {
                                    "groupId": "FG001",
                                    "comment": "This was an open period, without placebo arm, the number of subject on placebo is 0.",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "CNE",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "21"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "MC",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "20"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "AD",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "comment": "Open period was not proposed to AD subjects.",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "31"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "10"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Consent",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Lost to Follow-up",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Not otherwise specified",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "EGb761 120 mg",
                    "description": "EGb761 120 mg tablet twice a day for 4 weeks (Double-blind phase) for CNE, MC, and AD patients and 17 months (Open phase) for CNE and MC patients"
                },
                {
                    "id": "BG001",
                    "title": "Placebo",
                    "description": "Placebo 1 tablet twice a day for 4 weeks CNE, MC, and AD patients"
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "23"
                        },
                        {
                            "groupId": "BG001",
                            "value": "26"
                        },
                        {
                            "groupId": "BG002",
                            "value": "49"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "75.1",
                                            "spread": "6.2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "76.6",
                                            "spread": "5.3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "75.85",
                                            "spread": "5.25"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "32"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "17"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Body Mass Index (BMI)",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "kg/m^2",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "24.49",
                                            "spread": "4.46"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "25.03",
                                            "spread": "4.40"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "24.76",
                                            "spread": "4.43"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Educational Level",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "Level 1: Primary only",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Level 2: School certificate",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "7"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Level 3: Completed secondary",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "9"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Level 4: University",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "17"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "32"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "SECONDARY",
                    "title": "Change in Brain Glucose Metabolism in the MC and CNE Groups",
                    "description": "Brain glucose metabolism measured by 18FDG PET\n\nSUVBSA2 = \\[Brain radioactivity (Bq/cc)\\] / \\[Injected dose (MBq)/BSA2\\] x \\[Blood glucose (g/l)\\]\n\nBSA2(m\\^2) = 0.007184 x Height (cm)\\^0.35 x weight (kg)\\^0.80",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "SUVBSA2",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "14"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Cerebellum",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.07",
                                            "lowerLimit": "-0.3",
                                            "upperLimit": "0.1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0",
                                            "lowerLimit": "-0.5",
                                            "upperLimit": "0.2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left cerebral cortex",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.06",
                                            "lowerLimit": "-0.3",
                                            "upperLimit": "0.1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.08",
                                            "lowerLimit": "-0.5",
                                            "upperLimit": "0.1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left thalamus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.03",
                                            "lowerLimit": "-0.2",
                                            "upperLimit": "0.1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.02",
                                            "lowerLimit": "-0.8",
                                            "upperLimit": "0.1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left caudate nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.11",
                                            "lowerLimit": "-0.8",
                                            "upperLimit": "0.2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.01",
                                            "lowerLimit": "-0.6",
                                            "upperLimit": "0.2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left putamen nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.07",
                                            "lowerLimit": "-0.3",
                                            "upperLimit": "0.2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-0.5",
                                            "upperLimit": "0.3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left ventral striatum",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.05",
                                            "lowerLimit": "-0.5",
                                            "upperLimit": "0.3"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.09",
                                            "lowerLimit": "-0.5",
                                            "upperLimit": "0.1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left globus pallidus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "-0.3",
                                            "upperLimit": "0.2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.01",
                                            "lowerLimit": "-0.2",
                                            "upperLimit": "0.1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right cerebral cortex",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.07",
                                            "lowerLimit": "-0.3",
                                            "upperLimit": "0.1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.06",
                                            "lowerLimit": "-0.3",
                                            "upperLimit": "0.1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right thalamus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.04",
                                            "lowerLimit": "-0.3",
                                            "upperLimit": "0.2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.00",
                                            "lowerLimit": "-0.9",
                                            "upperLimit": "0.2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right caudate nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.03",
                                            "lowerLimit": "-0.6",
                                            "upperLimit": "0.2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.02",
                                            "lowerLimit": "-0.6",
                                            "upperLimit": "0.3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right putamen nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.04",
                                            "lowerLimit": "-0.5",
                                            "upperLimit": "0.2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.02",
                                            "lowerLimit": "-0.3",
                                            "upperLimit": "0.3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right ventral striatum",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.01",
                                            "lowerLimit": "-0.4",
                                            "upperLimit": "0.3"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.05",
                                            "lowerLimit": "-0.6",
                                            "upperLimit": "0.4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right globus pallidus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.06",
                                            "lowerLimit": "-0.3",
                                            "upperLimit": "0.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.06",
                                            "lowerLimit": "-0.2",
                                            "upperLimit": "0.6"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Clinical Dementia Rating (CDR) Score in MC and CNE Groups",
                    "description": "CDR is a structured interview to collect information regarding subject's memory in a standard way from both the patient and the helper. Scores are calculated using below scale; q CDR=No dementia (score: 0), q CDR=Very mild dementia (score: 0.5), q CDR=Mild dementia (score: 1), q CDR=Moderate dementia (score: 2) and q CDR=Severe dementia (score: 3).",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "CDR overall score",
                    "timeFrame": "From Baseline (Month 0) to Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patient"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "20"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "18"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "0.0",
                                            "upperLimit": "0.5"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-0.5",
                                            "upperLimit": "0.5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Geriatric Depression Scale (GDS) Score in MC and CNE Groups",
                    "description": "The Geriatric Depression Scale is a self-administered depression scale, which was developed as a basic screening measure for depression in older adults. By \"yes\" or \"no\" answers, scores permit to classify patients into groups of \"severely depressed\" (score of 21 to 30), \"moderately depressed\" (score of 11 to 20) and \"normal\" (score of 0 to10). It takes10 to 15 minutes to administer.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "GDS Score",
                    "timeFrame": "From Baseline (Month 0) to Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "17"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.00",
                                            "lowerLimit": "-6.0",
                                            "upperLimit": "8.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-5.0",
                                            "upperLimit": "9.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Verbal Fluency in MC and CNE Groups",
                    "description": "Subjects completed a verbal fluency test. Higher scores represent higher levels of verbal fluency. Minimum score=0 and Maximum score= N/A.\n\nLetter fluency: this task consists of enouncing as many words as possible that begin with a given letter of the alphabet. Participants are not allowed to use proper names.\n\nCategorical fluency: in this task participants are asked to list as many words as possible that belong to a given semantic category (e.g. animals, fruits, towns) Each condition foresees 60 sec of word generation time. The score corresponds to the number of words correctly given. The verbal fluency task measures semantic storage and executive retrieval functions.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Number of good answers",
                    "timeFrame": "From Baseline (Month 0) to Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "18"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Categorical verbal fluency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.50",
                                            "lowerLimit": "-14.0",
                                            "upperLimit": "11.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-2.00",
                                            "lowerLimit": "-16.0",
                                            "upperLimit": "6.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Lexical verbal fluency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.00",
                                            "lowerLimit": "-14.0",
                                            "upperLimit": "10.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.00",
                                            "lowerLimit": "-18.0",
                                            "upperLimit": "22.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Change in Brain Glucose Metabolism Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)",
                    "description": "Following statistical parametric mapping (SPM) analyses were performed by the Commissariat \u00e0 l'Energie Atomique (CEA):\n\n* The comparison between treatment groups separately for each group of elderly subjects (CNE and MC groups only)\n* The comparison between the two groups of elderly subjects (CNE and MC groups only) by treatment group\n\nFDG PET demonstrates reductions in the cerebral glucose metabolism that may occur a few years before the overt clinical manifestation of disease.\n\nSUVBSA2 = \\[Brain radioactivity (Bq/cc)\\] / \\[Injected dose (MBq)/BSA2\\] x \\[Blood glucose (g/l)\\]\n\nBSA2(m\\^2) = 0.007184 x Height (cm)\\^0.35 x weight (kg)\\^0.80\n\nStandardized Uptake Value (SUV) Body Surface Area (BSA)",
                    "populationDescription": "Intention to treat (ITT) population: All treated CNE and MC patients",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "SUVBSA2",
                    "timeFrame": "From Baseline (Month 0) to Week 4 (Month 1) - Double blind phase",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb761 120 mg (CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 4 weeks (Double-blind phase) for CNE, MC, and AD patients"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo (CNE)",
                            "description": "Placebo 1 tablet twice a day for 4 weeks for CNE, MC and AD patients"
                        },
                        {
                            "id": "OG002",
                            "title": "EGb761 120 mg (MC)",
                            "description": "EGb761 120 mg tablet twice a day for 4 weeks (Double-blind phase) for CNE, MC, and AD patients"
                        },
                        {
                            "id": "OG003",
                            "title": "Placebo (MC)",
                            "description": "Placebo 1 tablet twice a day for 4 weeks for CNE, MC and AD patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "11"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "10"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Cerebellum",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-3.40",
                                            "lowerLimit": "-16.4",
                                            "upperLimit": "18.7"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.07",
                                            "lowerLimit": "-22.8",
                                            "upperLimit": "33.5"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-7.58",
                                            "lowerLimit": "-29.7",
                                            "upperLimit": "26.4"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-3.09",
                                            "lowerLimit": "-16.4",
                                            "upperLimit": "22.4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left cerebral cortex",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-8.56",
                                            "lowerLimit": "-14.0",
                                            "upperLimit": "22.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.25",
                                            "lowerLimit": "-28.9",
                                            "upperLimit": "35.9"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.44",
                                            "lowerLimit": "-36.3",
                                            "upperLimit": "35.8"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-0.32",
                                            "lowerLimit": "-33.9",
                                            "upperLimit": "30.7"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left thalamus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-8.46",
                                            "lowerLimit": "-23.3",
                                            "upperLimit": "25.1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.06",
                                            "lowerLimit": "-39.6",
                                            "upperLimit": "37.4"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-2.09",
                                            "lowerLimit": "-35.2",
                                            "upperLimit": "30.1"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-6.19",
                                            "lowerLimit": "-38.9",
                                            "upperLimit": "31.2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left caudate nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.68",
                                            "lowerLimit": "-28.0",
                                            "upperLimit": "29.1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "4.60",
                                            "lowerLimit": "-23.8",
                                            "upperLimit": "49.6"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "2.16",
                                            "lowerLimit": "-35.8",
                                            "upperLimit": "53.4"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "3.27",
                                            "lowerLimit": "-51.4",
                                            "upperLimit": "25.3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left putamen nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.91",
                                            "lowerLimit": "-23.7",
                                            "upperLimit": "26.3"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.19",
                                            "lowerLimit": "-23.5",
                                            "upperLimit": "55.8"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "2.15",
                                            "lowerLimit": "-46.0",
                                            "upperLimit": "46.2"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-6.20",
                                            "lowerLimit": "-49.1",
                                            "upperLimit": "39.8"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left ventral striatum",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.49",
                                            "lowerLimit": "-53.5",
                                            "upperLimit": "19.7"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-7.29",
                                            "lowerLimit": "-30.4",
                                            "upperLimit": "67.5"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "2.37",
                                            "lowerLimit": "-22.3",
                                            "upperLimit": "24.4"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-4.62",
                                            "lowerLimit": "-53.8",
                                            "upperLimit": "33.8"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left globus pallidus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-4.33",
                                            "lowerLimit": "-26.3",
                                            "upperLimit": "19.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.26",
                                            "lowerLimit": "-9.4",
                                            "upperLimit": "39.2"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-7.75",
                                            "lowerLimit": "-28.5",
                                            "upperLimit": "14.0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-8.72",
                                            "lowerLimit": "-24.7",
                                            "upperLimit": "26.3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right cerebral cortex",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-7.49",
                                            "lowerLimit": "-25.3",
                                            "upperLimit": "21.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.19",
                                            "lowerLimit": "-29.4",
                                            "upperLimit": "38.2"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-7.11",
                                            "lowerLimit": "-32.5",
                                            "upperLimit": "35.5"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-6.59",
                                            "lowerLimit": "-36.1",
                                            "upperLimit": "31.3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right thalamus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-7.40",
                                            "lowerLimit": "-27.3",
                                            "upperLimit": "28.7"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-2.05",
                                            "lowerLimit": "-46.6",
                                            "upperLimit": "41.5"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-3.87",
                                            "lowerLimit": "-29.9",
                                            "upperLimit": "28.1"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-7.72",
                                            "lowerLimit": "-43.4",
                                            "upperLimit": "31.1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right caudate nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.59",
                                            "lowerLimit": "-36.2",
                                            "upperLimit": "29.1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.66",
                                            "lowerLimit": "-23.7",
                                            "upperLimit": "46.0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-9.21",
                                            "lowerLimit": "-34.2",
                                            "upperLimit": "40.9"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-6.45",
                                            "lowerLimit": "-41.3",
                                            "upperLimit": "16.7"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right putamen nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-6.31",
                                            "lowerLimit": "-42.9",
                                            "upperLimit": "30.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-2.73",
                                            "lowerLimit": "-39.1",
                                            "upperLimit": "52.8"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-8.84",
                                            "lowerLimit": "-41.7",
                                            "upperLimit": "41.8"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-5.36",
                                            "lowerLimit": "-50.4",
                                            "upperLimit": "25.5"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right ventral striatum",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-7.08",
                                            "lowerLimit": "-23.8",
                                            "upperLimit": "32.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.76",
                                            "lowerLimit": "-43.7",
                                            "upperLimit": "41.5"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-8.21",
                                            "lowerLimit": "-27.6",
                                            "upperLimit": "65.5"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-0.59",
                                            "lowerLimit": "-51.4",
                                            "upperLimit": "27.2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right globus pallidus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.04",
                                            "lowerLimit": "-21.1",
                                            "upperLimit": "17.3"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.72",
                                            "lowerLimit": "-22.1",
                                            "upperLimit": "40.4"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "-5.99",
                                            "lowerLimit": "-23.0",
                                            "upperLimit": "33.7"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-1.24",
                                            "lowerLimit": "-35.0",
                                            "upperLimit": "17.2"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Mini Mental Status Examination (MMSE) Score in MC and CNE Groups",
                    "description": "MMSE is a brief screening instrument used to assess cognitive function in elderly participants. It assesses orientation, memory, attention, ability to name objects, follow verbal and written commands, write a sentence, and copy figures. Total score ranges from 0 to 30, with a lower score indicating greater disease severity.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "MMSE Score",
                    "timeFrame": "From Baseline (Month 0) to Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "18"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "-2.0",
                                            "upperLimit": "1.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-6.0",
                                            "upperLimit": "4.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Clock Drawing Test Score in MC and CNE Groups",
                    "description": "Clock drawing test is a visuo-constructive task, where subjects are asked to draw the face of a clock in a pre-drawn circle and then to draw in the arms to denote 16:45 (a quarter to five). The drawing can then be evaluated by a quantitative scoring method, which is based on the degree of completion of the drawing. The scoring system ranges from 0 to 6 with higher scores reflecting a greater number of errors and more impairment.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Clock drawing test score",
                    "timeFrame": "From Baseline (Month 0) to Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "18"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "-3.0",
                                            "upperLimit": "2.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-5.0",
                                            "upperLimit": "3.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Cube Drawing Test Score in MC and CNE Groups",
                    "description": "Cube drawing: Subjects are asked to draw a cube by heart. In case of failure, a model of a cube is given to the subjects to copy.\n\nThe score system ranges from 0 (worse score) to 6 (best score). Score calculation is following: 1 point by face with 4 sides, 2 points for each face where each angle should be respected.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Cube drawing test score",
                    "timeFrame": "From Baseline (Month 0) to Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "18"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "-2.0",
                                            "upperLimit": "1.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-4.0",
                                            "upperLimit": "5.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests in MC and CNE Groups - Total Immediate Recall and Delayed Recall Scores of the Free and Cued Selective Reminding Test (FCSRT)",
                    "description": "Free and Cued Selective Reminding Test (FCSRT) Assessment of verbal episodic memory. By this test performances in free recalls, cued recalls and in a recognition task can be analysed, because the process of encoding is controlled.\n\nSubjects are asked to remember a list of 16 words. Three tasks of free and cued recalls, as well as one recognition task and one delayed recall give the scores.\n\nTotal recall is obtained by the addition of cued recalls to free recalls. Maximum score is 48 for immediate: 16 words X 3 corresponding to immediate free recall + immediate cued recall + immediate recognition test.\n\nMaximum score is 64 (better score) when delayed recall : 16 words X 4 . The minimum score is 0 (worse).",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Recall score",
                    "timeFrame": "From Baseline (Month 0) to Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "18"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Total Immediate Recall Score",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.00",
                                            "lowerLimit": "-1.0",
                                            "upperLimit": "10.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-10.0",
                                            "upperLimit": "11.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Total Delayed Recall Score",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "-4.0",
                                            "upperLimit": "6.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-4.0",
                                            "upperLimit": "5.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Age-Adjusted Logical Memory (MEM III) in MC and CNE Groups",
                    "description": "Subjects are asked to memorize two short stories, one consisting of 24, the other one of 26 information units. After the stories have been read aloud by the investigator, subjects are asked to enounce all items of information they can remember (free recall). Correctly reported items are added for each story. This test applies analytical capacities, as well as auditive and verbal synthesis, working memory and episodic memory.\n\nScore range from 0(worst) to 75 (better).",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Age adjusted score",
                    "timeFrame": "From Baseline (Month 0) to Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "18"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "17"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.00",
                                            "lowerLimit": "-5.0",
                                            "upperLimit": "6.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.00",
                                            "lowerLimit": "-4.0",
                                            "upperLimit": "7.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Age-Adjusted Wechsler Adult Intelligence Scale (WAIS) in MC and CNE Groups",
                    "description": "Wechsler Adult Intelligence Scale (WAIS) In this test subjects are asked to say how two seemingly dissimilar items might in fact be similar (14 item couples). This test involves especially abstract thinking and concept capacities.\n\nCognitive Tests-Age-Adjusted Wechsler Adult Intelligence Scale (WAIS): 19 tests on similarities. The items 1 to 5 are graded from 1 (good) to 0 (bad), and the items 6 to 19 are graded from 2 (good) to 0 (bad). Item 6 and 7 can be repeated. At the end, the worst total score is 0, the best total score is 33.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Age adjusted score",
                    "timeFrame": "From Baseline (Month 0) to Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "17"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "18"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.00",
                                            "lowerLimit": "-3.0",
                                            "upperLimit": "5.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.00",
                                            "lowerLimit": "-3.0",
                                            "upperLimit": "5.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Time to Perform Trail Making Test (TMT) in MC and CNE Groups",
                    "description": "TMT is a neuropsychological test of visual attention and task switching. The task requires a subject to 'connect-the-dots' of 25 consecutive numbers (1,2,3,etc.) on a sheet of paper or computer screen. The goal of the subject is to finish the test as quickly as possible and the time taken to complete the test is used as the primary performance metric (in seconds). The maximum time allowed is 300 seconds. A negative change score indicates improvement.\n\nFirst, in the TMT A, the subject has to connect numbers increasingly as fast as possible.\n\nThe TMT B requires the subject to connect and letters in an alternating pattern (1-A-2-B-3-C, etc.) in as little time as possible.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Seconds",
                    "timeFrame": "From Baseline (Month 0) to Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Task A (N=17,18)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.00",
                                            "lowerLimit": "-43.0",
                                            "upperLimit": "41.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.50",
                                            "lowerLimit": "-18.0",
                                            "upperLimit": "31.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Task B (N=17,16)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "-200.0",
                                            "upperLimit": "56.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-5.50",
                                            "lowerLimit": "-57.0",
                                            "upperLimit": "113.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Number of Subjects Conversion to Alzheimer's Dementia Diagnosed According to the DSM IV (Diagnostic of Dementia)",
                    "description": "The Diagnostic and Statistical Manual of Mental Disorders: 4th Edition of the American Psychiatric Association (DSM-IV, 1994) also outlines diagnostic criteria for dementia of the Alzheimer's type that are generally consistent with the NINCDS-ADRDA criteria.\n\nNational Institute of Neurological and Communicative Diseases and Stroke / Alzheimer's Disease and Related Disorders Association (NINCDS/ADRDA)",
                    "populationDescription": "ITT population. N=Number of subjects with assessment",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "timeFrame": "At Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Number of Subjects Conversion to Alzheimer's Dementia Diagnosed According to NINCDS-ADRDA (Diagnostic of Alzheimer's)",
                    "description": "The most widely accepted diagnostic criteria for probable AD are those offered by the National Institute of Neurological and Communicative Disorders and Stroke and by the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA; McKhann et al., 1984). These criteria include the presence of dementia established by clinical examination and confirmed by neuropsychological testing. The dementia is described as involving multiple, progressive cognitive deficits in older persons in the absence of disturbances of consciousness, presence of psychoactive substances, or any other medical, neurological, or psychiatric conditions that might in and of themselves account for these progressive deficits.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "timeFrame": "At Month 9",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-CDR Score in MC and CNE Groups",
                    "description": "CDR is a structured interview to collect information regarding subject's memory in a standard way from both the patient and the helper. Scores are calculated using below scale; q CDR=No dementia (score: 0), q CDR=Very mild dementia (score: 0.5), q CDR=Mild dementia (score: 1), q CDR=Moderate dementia (score: 2) and q CDR=Severe dementia (score: 3)",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "CDR overall score",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "12"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "0.0",
                                            "upperLimit": "0.5"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-0.5",
                                            "upperLimit": "0.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-GDS Score in MC and CNE Groups",
                    "description": "The Geriatric Depression Scale is a self-administered depression scale, which was developed as a basic screening measure for depression in older adults. By \"yes\" or \"no\" answers, scores permit to classify patients into groups of \"severely depressed\" (score of 21 to 30), \"moderately depressed\" (score of 11 to 20) and \"normal\" (score of 0 to10). It takes10 to 15 minutes to administer.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "GDS Score",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "12"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.00",
                                            "lowerLimit": "-7.0",
                                            "upperLimit": "17.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.50",
                                            "lowerLimit": "-5.0",
                                            "upperLimit": "7.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Verbal Fluency in MC and CNE Groups",
                    "description": "Subjects completed a verbal fluency test. Higher scores represent higher levels of verbal fluency. Minimum score=0 and Maximum score= N/A.\n\nLetter fluency: this task consists of enouncing as many words as possible that begin with a given letter of the alphabet. Participants are not allowed to use proper names.\n\nCategorical fluency: in this task participants are asked to list as many words as possible that belong to a given semantic category (e.g. animals, fruits, towns) Each condition foresees 60 sec of word generation time. The score corresponds to the number of words correctly given. The verbal fluency task measures semantic storage and executive retrieval functions.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Number of good answers",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (Open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "12"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "categorical verbal fluency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.00",
                                            "lowerLimit": "-18.0",
                                            "upperLimit": "20.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.00",
                                            "lowerLimit": "-9.0",
                                            "upperLimit": "10.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "lexical verbal fluency",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.00",
                                            "lowerLimit": "-16.0",
                                            "upperLimit": "18.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.50",
                                            "lowerLimit": "-7.0",
                                            "upperLimit": "22.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-MMSE Score in MC and CNE Groups",
                    "description": "MMSE is a brief screening instrument used to assess cognitive function in elderly participants. It assesses orientation, memory, attention, ability to name objects, follow verbal and written commands, write a sentence, and copy figures. Total score ranges from 0 to 30, with a lower score indicating greater disease severity.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "MMSE Score",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "12"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "-4.0",
                                            "upperLimit": "2.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-5.0",
                                            "upperLimit": "4.00"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Clock Drawing Test Score in MC and CNE Groups",
                    "description": "Clock drawing test is a visuo-constructive task, where subjects are asked to draw the face of a clock in a pre-drawn circle and then to draw in the arms to denote 16:45 (a quarter to five). The drawing can then be evaluated by a quantitative scoring method, which is based on the degree of completion of the drawing. The scoring system ranges from 0 to 6 with higher scores reflecting a greater number of errors and more impairment.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Clock drawing test score",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "12"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "-4.0",
                                            "upperLimit": "1.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-3.0",
                                            "upperLimit": "2.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Cube Drawing Test Score in MC and CNE Groups",
                    "description": "Cube drawing: Subjects are asked to draw a cube by heart. In case of failure, a model of a cube is given to the subjects to copy.\n\nThe score system ranges from 0 (worse score) to 6 (best score). Score calculation is following: 1 point by face with 4 sides, 2 points for each face where each angle should be respected.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Cube drawing test score",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "12"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "-6.0",
                                            "upperLimit": "2.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-4.0",
                                            "upperLimit": "2.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests in MC and CNE Groups - Total Immediate Recall and Delayed Recall Scores of FCSRT",
                    "description": "Free and Cued Selective Reminding Test (FCSRT) Assessment of verbal episodic memory. By this test performances in free recalls, cued recalls and in a recognition task can be analysed, because the process of encoding is controlled.\n\nSubjects are asked to remember a list of 16 words. Three tasks of free and cued recalls, as well as one recognition task and one delayed recall give the scores.\n\nTotal recall is obtained by the addition of cued recalls to free recalls. Maximum score is 48 for immediate: 16 words X 3 corresponding to immediate free recall + immediate cued recall + immediate recognition test.\n\nMaximum score is 64 (better score) when delayed recall : 16 words X 4 . The minimum score is 0 (worse).",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Recall score",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "12"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Total Immediate Recall Score of FCSRT",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.00",
                                            "lowerLimit": "-3.0",
                                            "upperLimit": "16.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.50",
                                            "lowerLimit": "-4.0",
                                            "upperLimit": "8.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Total Delayed Recall Score of FCSRT",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "-6.0",
                                            "upperLimit": "6.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-2.0",
                                            "upperLimit": "2.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Age-Adjusted Logical Memory (MEM III) in MC and CNE Groups",
                    "description": "Subjects are asked to memorize two short stories, one consisting of 24, the other one of 26 information units. After the stories have been read aloud by the investigator, subjects are asked to enounce all items of information they can remember (free recall). Correctly reported items are added for each story. This test applies analytical capacities, as well as auditive and verbal synthesis, working memory and episodic memory.\n\nScore range from 0(worst) to 75 (better).",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Age adjusted score",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "11"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "lowerLimit": "-4.0",
                                            "upperLimit": "7.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.00",
                                            "lowerLimit": "-4.0",
                                            "upperLimit": "9.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Age-Adjusted WAIS in MC and CNE Groups",
                    "description": "Wechsler Adult Intelligence Scale (WAIS) In this test subjects are asked to say how two seemingly dissimilar items might in fact be similar (14 item couples). This test involves especially abstract thinking and concept capacities.\n\nCognitive Tests-Age-Adjusted Wechsler Adult Intelligence Scale (WAIS): 19 tests on similarities. The items 1 to 5 are graded from 1 (good) to 0 (bad), and the items 6 to 19 are graded from 2 (good) to 0 (bad). Item 6 and 7 can be repeated. At the end, the worst total score is 0, the best total score is 33.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Age adjusted score",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "12"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.00",
                                            "lowerLimit": "-3.0",
                                            "upperLimit": "4.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.50",
                                            "lowerLimit": "-2.0",
                                            "upperLimit": "5.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Cognitive Tests-Time to Perform TMT in MC and CNE Groups",
                    "description": "TMT is a neuropsychological test of visual attention and task switching. The task requires a subject to 'connect-the-dots' of 25 consecutive numbers (1,2,3,etc.) on a sheet of paper or computer screen. The goal of the subject is to finish the test as quickly as possible and the time taken to complete the test is used as the primary performance metric (in seconds). The maximum time allowed is 300 seconds. A negative change score indicates improvement.\n\nFirst, in the TMT A, the subject has to connect numbers increasingly as fast as possible.The TMT B requires the subject to connect and letters in an alternating pattern (1-A-2-B-3-C, etc.) in as little time as possible.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "Seconds",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Task A (N=18,12)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-3.00",
                                            "lowerLimit": "-59.0",
                                            "upperLimit": "8.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.00",
                                            "lowerLimit": "-31.0",
                                            "upperLimit": "29.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Task B (N=18,11)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-4.50",
                                            "lowerLimit": "-213.0",
                                            "upperLimit": "29.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-9.00",
                                            "lowerLimit": "-76.0",
                                            "upperLimit": "100.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Number of Subjects Conversion to Alzheimer's Dementia Diagnosed According to the DSM IV (Diagnostic of Dementia)",
                    "description": "The Diagnostic and Statistical Manual of Mental Disorders: 4th Edition of the American Psychiatric Association (DSM-IV, 1994) also outlines diagnostic criteria for dementia of the Alzheimer's type that are generally consistent with the NINCDS-ADRDA criteria.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "timeFrame": "At Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Number of Subjects Conversion to Alzheimer's Dementia Diagnosed According to NINCDS-ADRDA (Diagnostic of Alzheimer's)",
                    "description": "The most widely accepted diagnostic criteria for probable AD are those offered by the National Institute of Neurological and Communicative Disorders and Stroke and by the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA; McKhann et al., 1984). These criteria include the presence of dementia established by clinical examination and confirmed by neuropsychological testing. The dementia is described as involving multiple, progressive cognitive deficits in older persons in the absence of disturbances of consciousness, presence of psychoactive substances, or any other medical, neurological, or psychiatric conditions that might in and of themselves account for these progressive deficits.",
                    "populationDescription": "ITT population. N=Number of subjects with assessment.",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "timeFrame": "At Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb 120 mg (Open Phase - CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb 120 mg (Open Phase - MC)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Incidence of Adverse Events (AEs)",
                    "description": "The relationship of an adverse event to the study medication will be classified according to the following criteria:\n\nRelated : reports including good reasons and sufficient information (e.g. temporal relationship, dose-response relationship, pharmacology, positive de-challenge and/or re-challenge) to assume a causal relationship with the study drug in the sense that it is plausible, conceivable, or likely\n\nNot related: reports including good reasons and sufficient information (e.g. no temporal relationship and/or attributable to concurrent disease or other drugs) to rule out a causal relationship with the study drug.",
                    "populationDescription": "Safety population. CNE patients withdrew during the double-blind phase and were also not included in the safety population for open phase (17 months).",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "timeFrame": "Up to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb761 120 mg (Double-blind Phase)",
                            "description": "EGb761 120 mg twice a day for 4 weeks (double-blind phase) for CNE, MC and AD patients"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo (Double-blind Phase)",
                            "description": "Placebo 1 tablet twice a day for 4 weeks (double-blind phase) for CNE, MC and AD patients"
                        },
                        {
                            "id": "OG002",
                            "title": "EGb761 120 mg (Open Phase)",
                            "description": "EGb761 120 mg twice a day for 17 months (open phase) for MC and CNE patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "23"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "26"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "41"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Any Adverse Events",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "25"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Any Treatment Emergent",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "25"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Intensity of Severe Treatment Emergent AEs (TEAEs)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "6"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Intensity of moderate TEAEs",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "14"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Intensity of mild TEAEs",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "20"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Causality of Related TEAEs",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Causality of Non Related TEAEs",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "25"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Causality and Intensity",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "At least one related & severe",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "At least one related & moderate",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "At least one related & mild",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "At least one not related & severe",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "6"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "At least one not related & moderate",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "14"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "At least one not related & mild",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "20"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "TEAEs leading to withdrawal",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "TEAES Leading to Death",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Serious AEs (SAEs)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "6"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Non SAEs",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "23"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Brain Morphology in the MC and CNE Groups as Determined by the Change in Voxel Size",
                    "description": "Evolution of brain morphology (degree of cortical atrophy) after 18 months with EGb761, using MRI voxel based morphometry",
                    "populationDescription": "ITT population.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEDIAN",
                    "dispersionType": "Full Range",
                    "unitOfMeasure": "mm3",
                    "timeFrame": "From Baseline (Month 0) to Month 18",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EGb761 120 mg (CNE)",
                            "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for CNE patients"
                        },
                        {
                            "id": "OG001",
                            "title": "EGb761 120 mg (MC)",
                            "description": "EGb761 120 mg 17 months (open phase) for MC patients"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Cerebellum",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6454.00",
                                            "lowerLimit": "-42470.0",
                                            "upperLimit": "30372.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "6168.50",
                                            "lowerLimit": "-38855.2",
                                            "upperLimit": "65345.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left cerebral cortex",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5765.50",
                                            "lowerLimit": "-52347.0",
                                            "upperLimit": "97071.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "32428.00",
                                            "lowerLimit": "-103527",
                                            "upperLimit": "88300.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left thalamus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "145.20",
                                            "lowerLimit": "-418.9",
                                            "upperLimit": "1023.1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "24.57",
                                            "lowerLimit": "-794.8",
                                            "upperLimit": "780.4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left caudate nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "154.68",
                                            "lowerLimit": "-387.3",
                                            "upperLimit": "1105.3"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "140.97",
                                            "lowerLimit": "-827.2",
                                            "upperLimit": "1384.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left putamen nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-17.14",
                                            "lowerLimit": "-346.4",
                                            "upperLimit": "676.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "4.00",
                                            "lowerLimit": "-842.6",
                                            "upperLimit": "481.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left ventral striatum",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "65.26",
                                            "lowerLimit": "-99.0",
                                            "upperLimit": "157.6"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "81.56",
                                            "lowerLimit": "-57.4",
                                            "upperLimit": "236.4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Left globus pallidus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "104.75",
                                            "lowerLimit": "-86.2",
                                            "upperLimit": "380.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "50.66",
                                            "lowerLimit": "-208.7",
                                            "upperLimit": "431.8"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right cerebral cortex",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5853.00",
                                            "lowerLimit": "-40148.0",
                                            "upperLimit": "103200.0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38955.50",
                                            "lowerLimit": "-102169",
                                            "upperLimit": "97667.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right thalamus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "144.83",
                                            "lowerLimit": "-715.7",
                                            "upperLimit": "669.6"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "14.90",
                                            "lowerLimit": "-570.1",
                                            "upperLimit": "755.1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right caudate nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "228.74",
                                            "lowerLimit": "-274.2",
                                            "upperLimit": "519.6"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "303.66",
                                            "lowerLimit": "-223.5",
                                            "upperLimit": "1084.4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right putamen nucleus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "8.36",
                                            "lowerLimit": "-229.6",
                                            "upperLimit": "663.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-78.94",
                                            "lowerLimit": "-520.5",
                                            "upperLimit": "343.9"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right ventral striatum",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "65.15",
                                            "lowerLimit": "-5.5",
                                            "upperLimit": "198.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "70.85",
                                            "lowerLimit": "-13.0",
                                            "upperLimit": "287.7"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Right globus pallidus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "84.68",
                                            "lowerLimit": "-293.0",
                                            "upperLimit": "312.6"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "64.82",
                                            "lowerLimit": "-119.3",
                                            "upperLimit": "318.8"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "0",
            "timeFrame": "Up to month 18 follow up",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "EGb761 120 mg (Double-blind Phase)",
                    "description": "EGb761 120 mg tablet twice a day for 4 weeks (double-blind phase) for CNE, MC, and AD patients",
                    "seriousNumAffected": 1,
                    "seriousNumAtRisk": 23,
                    "otherNumAffected": 5,
                    "otherNumAtRisk": 23
                },
                {
                    "id": "EG001",
                    "title": "Placebo (Double-blind Phase)",
                    "description": "Placebo 1 tablet twice a day for 4 weeks (double-blind phase) for CNE, MC, and AD patients",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 26,
                    "otherNumAffected": 9,
                    "otherNumAtRisk": 26
                },
                {
                    "id": "EG002",
                    "title": "EGb761 120 mg (Open Phase)",
                    "description": "EGb761 120 mg tablet twice a day for 17 months (open phase) for MC and CNE patients",
                    "seriousNumAffected": 6,
                    "seriousNumAtRisk": 41,
                    "otherNumAffected": 23,
                    "otherNumAtRisk": 41
                }
            ],
            "seriousEvents": [
                {
                    "term": "Transient ischaemic attack",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Atrial fibrillation",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Cholelithiasis",
                    "organSystem": "Hepatobiliary disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Sciatica",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Spinal cord compression",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Subclavian artery stenosis",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Lung neoplasm",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Constipation",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 3,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Gastro esophageal reflux disease",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 2,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Aerophagia",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Nausea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Food poisoning",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Gastrointestinal disorder",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Vomiting",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Dementia Alzheimer's type",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 2,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Essential Tremor",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Dizziness",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Hemicephalalgia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Neuralgia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Syncope vasovagal",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Bronchitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 2,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Pharyngitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Bronchopneumonia",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Ear infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Gastroenteritis viral",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Herpes zoster",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Tracheobronchitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Dry skin",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Pigmentation disorder",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Rash",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Dermal cyst",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Depression",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 3,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Insomnia",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 3,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Anxiety",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Delirium",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 5,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Spinal fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Wound",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Procedural nausea",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Palpitations",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Tachycardia",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Dyspnoea",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 2,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Rhinitis allergic",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Back pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Arthralgia",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 2,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Musculoskeletal pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Neck pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Tendonitis",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Myalgia",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Asthenia",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Fatigue",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Oedema peripheral",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Vertigo",
                    "organSystem": "Ear and labyrinth disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 2,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Macular degeneration",
                    "organSystem": "Eye disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Vision blurred",
                    "organSystem": "Eye disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Cataract",
                    "organSystem": "Eye disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Urinary incontinence",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Renal colic",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Orthostatic hypotension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Haematoma",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Hypertension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Hypercholesterolaemia",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Benign prostatic hyperplasia",
                    "organSystem": "Reproductive system and breast disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 41
                        }
                    ]
                },
                {
                    "term": "Diarrhoea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 23
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 26
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 2,
                            "numAtRisk": 41
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Medical Director, Neurology",
                "organization": "Ipsen",
                "email": "clinical.trials@ipsen.com",
                "phone": "clinical.trials@ipsen.com"
            }
        }
    },
    "target_category": "Cognitive enhancer",
    "drug": [
        "EGb761 (standardized Ginkgo biloba leaf extract)"
    ],
    "placebo": [
        "placebo"
    ],
    "explanation_target": [
        "Reason: The intervention is EGb761\u00ae, a standardized Ginkgo biloba leaf extract used to improve cognition and brain metabolism rather than a monoclonal antibody or a small-molecule anti-amyloid/tau agent. The trial measures change in cerebral glucose metabolism (18F\u2011FDG PET) and includes cognitive/memory groups, indicating a symptomatic/cognitive enhancement aim rather than a targeted anti\u2011amyloid or anti\u2011tau disease\u2011modifying mechanism. \ue200cite\ue202turn0search2\ue202turn0search6\ue201",
        "Act: EGb761 is a phytopharmaceutical (standardized Ginkgo extract containing ~24% flavone glycosides and ~6% terpene lactones) with proposed neuroprotective, antioxidant, and vascular effects and has been studied for symptomatic cognitive improvement in elderly and dementia populations \u2014 i.e., a cognitive enhancer/symptomatic treatment. The comparator in the described trial is placebo. \ue200cite\ue202turn0search0\ue202turn0search1\ue201",
        "Web search results (supporting sources): EGb 761 overview and composition (PubMed review). \ue200cite\ue202turn0search2\ue201; Pharmacology and clinical use summary (AAFP). \ue200cite\ue202turn0search1\ue201; Review of CNS effects and symptomatic use in dementia (PubMed review). \ue200cite\ue202turn0search6\ue201; Example randomized placebo\u2011controlled trial showing cognitive effects of EGb761. \ue200cite\ue202turn0search4\ue201",
        "Reflect: Classification as 'Cognitive enhancer' aligns with the drug type (herbal extract used to improve cognitive function/brain metabolism) and the trial endpoints (FDG\u2011PET change in glucose metabolism, symptomatic follow\u2011up). There is no indication in the description that EGb761 specifically targets core AD pathology (amyloid or tau) with a biologic or targeted small molecule mechanism, so 'Disease\u2011targeted biologic' and 'Disease\u2011targeted small molecule' are not appropriate. No neuropsychiatric\u2011only endpoint (e.g., agitation) is described, so 'Neuropsychiatric symptom improvement' is not appropriate."
    ],
    "agent_type": "R) Multi-target",
    "explanation_agent": [
        "Reason: The investigational product is EGb761\u00ae, a standardized Ginkgo biloba leaf extract used here as a symptomatic/cognitive enhancer (FDG\u2011PET change and cognitive endpoints). EGb761 has multiple putative actions \u2014 antioxidant and neuroprotective effects, vasoactive/vascular effects, platelet\u2011activating factor antagonism and other pharmacologic activities \u2014 rather than a single, specific molecular target such as amyloid\u2011beta or tau. \ue200cite\ue202turn0search7\ue202turn0search5\ue201",
        "Act: Key extracted details: EGb761 is a standardized extract (typical specification ~24% flavone glycosides and ~6% terpene/terpene\u2011lactones). Preclinical and biochemical work and reviews describe antioxidant and neuroprotective activity, vascular/vasoactive properties, and even some reports of effects on amyloid fibrillization in vitro \u2014 i.e., several different biological pathways are implicated rather than one defined CADRO target. Because multiple mechanisms/pathways are indicated, I assign 'R) Multi\u2011target'. \ue200cite\ue202turn0search0\ue202turn0search4\ue202turn0search2\ue201",
        "Reflect: This classification aligns with the trial description (symptomatic cognitive enhancement / brain glucose metabolism endpoints rather than a stated single disease\u2011modifying target) and with the pharmacology of EGb761 which spans oxidative stress, neuroprotection/synaptic support, and vascular effects. If the user prefers a single\u2011domain mapping (less precise), plausible single CADRO categories would include G) Oxidative Stress, K) Vasculature, or M) Synaptic Plasticity/Neuroprotection \u2014 but because the extract acts via several pathways, 'R) Multi\u2011target' is the most accurate CADRO assignment. \ue200cite\ue202turn0search7\ue202turn0search2\ue201",
        "Output: Assigned category \u2014 R) Multi-target. Brief rationale: EGb761 is a multi\u2011component herbal extract with antioxidant, neuroprotective and vascular/vasoactive actions and has been tested as a symptomatic cognitive enhancer; no single, specific CADRO target was specified in the trial description or in primary pharmacologic characterizations, so the multi\u2011target category is appropriate. \ue200cite\ue202turn0search5\ue202turn0search7\ue201",
        "Web search results (supporting sources used): 1) Composition and clinical use of standardized Ginkgo extract (EGb761) \u2014 composition/specification and clinical reviews. \ue200cite\ue202turn0search0\ue202turn0search7\ue201; 2) Analytical comparisons and standardization of Ginkgo extracts (24% flavone glycosides / 6% terpene trilactones typical for EGb761). \ue200cite\ue202turn0search4\ue201; 3) Study showing EGb761 components and investigation of inhibitory activity toward A\u03b2 fibril formation (preclinical biochemical evidence). \ue200cite\ue202turn0search2\ue201; 4) Trial description listing FDG\u2011PET brain glucose metabolism endpoint for EGb761 in elderly groups (trial record). \ue200cite\ue202turn0search5\ue201"
    ]
}